Search academic texts

Information × Registration Number 0224U002991, 0121U110087 , R & D reports Title Individualization of combined treatment of colorectal cancer of III-IV stages of the disease based on the study of molecular markers of redox status of tumor progression popup.stage_title Head Lukashenko Andrii V., Доктор медичних наук Registration Date 23-03-2024 Organization National Cancer Institute popup.description2  The object of the study: 1390 patients with colorectal cancer with metastatic liver damage for the period from September 2000 to December 2023, patients underwent surgical and combined treatment in the conditions of the clinic of the National Cancer Institute. Research methods: general clinical research methods (physical, laboratory methods, assessment of the general condition of the patient), clinical and instrumental (endoscopic methods, radiological and functional diagnostics) - to determine the state of internal organs and the degree of tumor spread. Morphological studies to verify the diagnosis, estimate the spread and degree of differentiation of the tumor; to determine the characteristics of the therapeutic pathomorphosis of the neoplasm. At the light-optical level: pathohistological, morphometric and histochemical (using hematoxylin-eosin staining; Alcian blue according to Steedman, according to Masson, SHIK-reactions). Biophysical research methods: determination of the level of generation of superoxide radicals, NO by neutrophils and tissue cells, low- and high-spin forms of cytochrome P-450 using the method of electron paramagnetic resonance and SpinTraps technology. Polyacrylamide gel zymography method for determining active and latent forms of MMP-2 and MMP-9 gelatinases. Statistical research methods. This work presents a solution to an actual problem in oncology, improved oncological prognosis in patients with metastatic liver damage from colorectal cancer by using a parenchymal-sparing surgical strategy and researching redox-dependent predictors of early progression. As a result of the performed NDR, a parenchymal-sparing strategy (PCS) was developed, which allows safe and effective removal of metastatic foci within the right “venous core” of the liver, portal and caval confluence, paracaval and caudal parts of S1, deep sites S4, S5, S8, central sites of the liver . Product Description popup.authors Burlaka Anton A. Zakalska Khrystyna А. Kopchak Kostiantyn V. Lisnyi Ivan І. Yatsyna Oleksandr І. popup.nrat_date 2024-03-23 Close